| Old Articles: <Older 20081-20090 Newer> |
 |
The Motley Fool January 25, 2007 Rich Duprey |
EZCORP Profits Easily The pawnshop and payday lender ties its future profits to expansion. It turned in a first-quarter performance that far exceeded analyst expectations, even though it was not able to open as many stores as it had intended.  |
The Motley Fool January 25, 2007 Rich Duprey |
Ryland Puts the Hammer Down The homebuilder manages to exceed expectations and raise home prices. Investors, take note.  |
The Motley Fool January 25, 2007 Rick Aristotle Munarriz |
Mothers Work Is Never Done The largest maternity retailer stumbles, but still looks fruitful for investors.  |
The Motley Fool January 25, 2007 Tom Taulli |
Aladdin Dusting Off Its Lamp A new line of products for the security software developer could boost revenues. Investors, take note.  |
The Motley Fool January 25, 2007 Rich Duprey |
Ryland Is All Riled Up: Fool by Numbers The homebuilder released fourth-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...  |
The Motley Fool January 25, 2007 |
Ennui for Ethan Allen?: Fool by Numbers The furniture company released its second-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...  |
The Motley Fool January 25, 2007 |
1-800-Flowers Blossoms: Fool by Numbers The florist released second-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...  |
The Motley Fool January 25, 2007 Michael Leibert |
What's the Next Act, B of A? Bank of America remains an extremely well-run company with considerable competitive strengths. But a difficult operating environment and challenging comparisons to an especially successful 2006 will make it harder for the company to impress investors in 2007.  |
The Motley Fool January 25, 2007 Tom Taulli |
Satyam's Multisourced Success The No. 4 player in Indian IT consulting runs an appealing business. Investors, take note.  |
The Motley Fool January 25, 2007 Charly Travers |
The Best Drug Stock for 2007 Is ... Is anyone surprised that the largest biotech company in the world, Genentech, came out on top?  |
| <Older 20081-20090 Newer> Return to current articles. |